Variances in the level of of COX-2 and iNOS in different grades of endometrial cancer.

CONCLUSIONS: Our findings suggest that changes in expression of COX-2 and iNOS may be potentially useful in predicting the progression of endometrial cancer and treatment effectiveness. PMID: 31533599 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/31533599?dopt=Abstract

Source: Current Pharmaceutical Biotechnology - September 16, 2019 Category: Biotechnology Authors: Oplawski M, Dziobek K, Zmarzły N, Grabarek B, Kiełbasiński R, Kieszkowski P, Januszyk P, Talkowski K, Plewka A, Boroń D Tags: Curr Pharm Biotechnol Source Type: research